This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kostrikis, L. G.
Right arrow Articles by Moore, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kostrikis, L. G.
Right arrow Articles by Moore, J. P.

 Previous Article  |  Next Article 

Journal of Virology, December 1999, p. 10264-10271, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants

Leondios G. Kostrikis,1,* Avidan U. Neumann,2 Bruce Thomson,3 Bette T. Korber,4 Paul McHardy,1 Rose Karanicolas,1 Lisa Deutsch,2 Yaoxing Huang,1 Judy F. Lew,5 Kenneth McIntosh,6 Henry Pollack,7 William Borkowsky,7 Hans M. L. Spiegel,1 Paul Palumbo,8 James Oleske,8 Arlene Bardeguez,8 Katherine Luzuriaga,9 John Sullivan,9 Steven M. Wolinsky,10 Richard A. Koup,11 David D. Ho,1 and John P. Moore1

Aaron Diamond AIDS Research Center, The Rockefeller University,1 and New York University Medical Center,7 New York, New York; Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel2; Clinical Trials and Surveys Corporation, Baltimore, Maryland3; Los Alamos National Laboratory, Los Alamos, New Mexico4; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland5; Department of Pediatrics, Harvard Medical School, Boston,6 and University of Massachusetts Medical School, Worcester,9 Massachusetts; Department of Pediatrics, UMDNJ Medical School, Newark, New Jersey8; Department of Medicine, Northwestern University Medical School, Chicago, Illinois10; and Department of Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas11

Received 19 July 1999/Accepted 7 September 1999

There are natural mutations in the coding and noncoding regions of the human immunodeficiency virus type 1 (HIV-1) CC-chemokine coreceptor 5 (CCR5) and in the related CCR2 protein (the CCR2-64I mutation). Individuals homozygous for the CCR5-Delta 32 allele, which prevents CCR5 expression, strongly resist HIV-1 infection. Several genetic polymorphisms have been identified within the CCR5 5' regulatory region, some of which influence the rate of disease progression in adult AIDS study cohorts. We genotyped 1,442 infants (1,235 uninfected and 207 HIV-1 infected) for five CCR5 and CCR2 polymorphisms: CCR5-59353-T/C, CCR5-59356-C/T CCR5-59402-A/G, CCR5-Delta 32, and CCR2-64I. The clinical significance of each genotype was assessed by measuring whether it influenced the rate of perinatal HIV-1 transmission among 667 AZT-untreated mother-infant pairs (554 uninfected and 113 HIV-1 infected). We found that the mutant CCR5-59356-T allele is relatively common in African-Americans (20.6% allele frequency among 552 infants) and rare in Caucasians and Hispanics (3.4 and 5.6% of 174 and 458 infants, respectively; P < 0.001). There were 38 infants homozygous for CCR5-59356-T, of whom 35 were African-Americans. Among the African-American infants in the AZT-untreated group, there was a highly significant increase in HIV-1 transmission to infants with two mutant CCR5-59356-T alleles (47.6% of 21), compared to those with no or one mutant allele (13.4 to 14.1% of 187 and 71, respectively; P < 0.001). The increased relative risk was 5.9 (95% confidence interval, 2.3 to 15.3; P < 0.001). The frequency of the CCR5-59356-T mutation varies between population groups in the United States, a low frequency occurring in Caucasians and a higher frequency occurring in African-Americans. Homozygosity for CCR5-59356-T is strongly associated with an increased rate of perinatal HIV-1 transmission.


* Corresponding author. Mailing address: Aaron Diamond AIDS Research Center, 455 First Ave., New York, NY 10016. Phone: (212) 448-5021. Fax: (212) 725-1126. E-mail: lkostrik{at}adarc.org.


Journal of Virology, December 1999, p. 10264-10271, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Liu, Y., Woodward, A., Zhu, H., Andrus, T., McNevin, J., Lee, J., Mullins, J. I., Corey, L., McElrath, M. J., Zhu, T. (2009). Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners. J. Virol. 83: 10821-10829 [Abstract] [Full Text]  
  • Kiryluk, K., Martino, J., Gharavi, A. G. (2007). Genetic Susceptibility, HIV Infection, and the Kidney. CJASN 2: S25-S35 [Abstract] [Full Text]  
  • Hladik, F., Liu, H., Speelmon, E., Livingston-Rosanoff, D., Wilson, S., Sakchalathorn, P., Hwangbo, Y., Greene, B., Zhu, T., McElrath, M. J. (2005). Combined Effect of CCR5-{Delta}32 Heterozygosity and the CCR5 Promoter Polymorphism -2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission. J. Virol. 79: 11677-11684 [Abstract] [Full Text]  
  • Kawamura, T., Gulden, F. O., Sugaya, M., McNamara, D. T., Borris, D. L., Lederman, M. M., Orenstein, J. M., Zimmerman, P. A., Blauvelt, A. (2003). R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl. Acad. Sci. USA 100: 8401-8406 [Abstract] [Full Text]  
  • Kostrikis, L. G., Touloumi, G., Karanicolas, R., Pantazis, N., Anastassopoulou, C., Karafoulidou, A., Goedert, J. J., Hatzakis, A. (2002). Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load. J. Virol. 76: 10099-10108 [Abstract] [Full Text]  
  • Tang, J., Shelton, B., Makhatadze, N. J., Zhang, Y., Schaen, M., Louie, L. G., Goedert, J. J., Seaberg, E. C., Margolick, J. B., Mellors, J., Kaslow, R. A. (2002). Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression. J. Virol. 76: 662-672 [Abstract] [Full Text]  
  • Venkatesan, S., Petrovic, A., Locati, M., Kim, Y.-O., Weissman, D., Murphy, P. M. (2001). A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression. J. Biol. Chem. 276: 40133-40145 [Abstract] [Full Text]  
  • Kuhmann, S. E., Madani, N., Diop, O. M., Platt, E. J., Morvan, J., Muller-Trutwin, M. C., Barre-Sinoussi, F., Kabat, D. (2001). Frequent Substitution Polymorphisms in African Green Monkey CCR5 Cluster at Critical Sites for Infections by Simian Immunodeficiency Virus SIVagm, Implying Ancient Virus-Host Coevolution. J. Virol. 75: 8449-8460 [Abstract] [Full Text]  
  • Hansasuta, P., Rowland-Jones, S. L (2001). HIV-1 transmission and acute HIV-1 infection. Br Med Bull 58: 109-127 [Abstract] [Full Text]  
  • Hogan, C. M., Hammer, S. M. (2001). Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics. ANN INTERN MED 134: 978-996 [Abstract] [Full Text]  
  • Gonzalez, E., Dhanda, R., Bamshad, M., Mummidi, S., Geevarghese, R., Catano, G., Anderson, S. A., Walter, E. A., Stephan, K. T., Hammer, M. F., Mangano, A., Sen, L., Clark, R. A., Ahuja, S. S., Dolan, M. J., Ahuja, S. K. (2001). Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha : Impact on the epidemiology of the HIV-1 pandemic. Proc. Natl. Acad. Sci. USA 98: 5199-5204 [Abstract] [Full Text]  
  • Shetty, A. K., Maldonado, Y. (2001). Preventing Mother-to-Child Transmission of HIV-1: An International Perspective. NeoReviews 2: e75-82 [Full Text]  
  • Shetty, A. K., Maldonado, Y. (2001). HIV transmission Prevention of Perinatal HIV-1 Transmission in the United States. NeoReviews 2: e83-93 [Full Text]  
  • Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J., Olson, W. C. (2001). Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140. J. Virol. 75: 579-588 [Abstract] [Full Text]  
  • Sabbe, R., Picchio, G. R., Pastore, C., Chaloin, O., Hartley, O., Offord, R., Mosier, D. E. (2001). Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression. J. Virol. 75: 661-671 [Abstract] [Full Text]  
  • McGowan, J. P., Shah, S. S. (2000). Prevention of perinatal HIV transmission during pregnancy. J Antimicrob Chemother 46: 657-668 [Abstract] [Full Text]  
  • Pollakis, G., Kang, S., Kliphuis, A., Chalaby, M. I. M., Goudsmit, J., Paxton, W. A. (2001). N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization. J. Biol. Chem. 276: 13433-13441 [Abstract] [Full Text]  
  • Sullivan, A. D., Wigginton, J., Kirschner, D. (2001). The coreceptor mutation CCR5Delta 32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc. Natl. Acad. Sci. USA 98: 10214-10219 [Abstract] [Full Text]